The thrombophilia test, partially performed one year after the acute event, revealed positive results: antithrombin III deficit, low activated protein C resistance, and hyperhomocysteinemia, thus making her a candidate for chronic anticoagulation. Here, SERPINC1 is linked to Rare hereditary thrombophilia.